(Press-News.org) Tampa, FL, USA – November 20, 2025 – The Global Virus Network (GVN) is pleased to announce that, for the first time, it is awarding pandemic preparedness research grants, totaling $160,000, to GVN scientists across four continents. These awards support innovative, investigator-led projects designed to enhance viral surveillance, early detection, and scientific preparedness, particularly in regions vulnerable to emerging and re-emerging viral threats.
“These projects represent exactly the kind of targeted, interdisciplinary innovation that can help prevent the next pandemic,” said Robert C. Gallo, MD, co-founder and international scientific director of the GVN. “From the study of microbes and AI to on-the-ground diagnostics in rural communities, these teams are building a new global frontline for outbreak detection and response.” Dr. Gallo is also the James P. Cullison Professor of Medicine and director of the Institute of Translational Virology and Innovation at the University of South Florida Morsani College of Medicine, and director of the Microbial Oncology Program at Tampa General Hospital (TGH) Cancer Institute.
Grant Recipients Include:
Moussa Sarr, MD, MPH of the Institut de Recherche en Santé, de Surveillance Epidemiologique et de Formations (IRESEFF), Senegal, received a grant for a six-month pilot to deploy decentralized diagnostics and an AI-driven surveillance system to combat recurring dengue epidemics in Senegal.
Ann Kathrin Dietzsch, PhD of the Robert Koch-Institut (RKI), Germany, was awarded a grant for virus discovery in elephants and mosquitoes in Sri Lanka, addressing zoonotic spillover risks.
Ana Da Silva Filipe, PhD of the University of Glasgow, UK, received a grant to profile tick-borne viruses in Kenyan pastoralist communities using next-generation sequencing and serological assays.
Caitlin Cotter, DVM, MPH, PhD of the University of Texas Medical Branch (UTMB), USA, received a grant for a One Health surveillance system targeting Lassa fever in Nigeria, focusing on bioaerosol environmental sampling.
Jorge Osorio, DVM, PhD, MS of the University of Wisconsin in a collaboration with the One Health Consortium, Colombia, received a grant to develop a rapid field-based test to differentiate dengue serotypes using loop-mediated isothermal amplification (LAMP) and IntelliSense technology.
Suleiman Idris Ahmad, MBBS, MPH of the Abbott Pandemic Defense Coalition, Nigeria, was awarded a grant to expand post-mortem surveillance for infectious causes of death in Sokoto State, Nigeria, using polymerase chain reaction testing, rapid diagnostic tests, and metagenomic next-generation sequencing.
Joshua Anzinger, PhD of the University of the West Indies, Jamaica, received a grant to establish dengue wastewater surveillance in Kingston in partnership with the University of Miami.
Victoria Etuk, MPH of the Institute of Human Virology, Nigeria, was awarded a grant to build a wastewater-based system in Nigeria for early detection of emerging pathogens, using metagenomics, geospatial mapping, and AI tools.
Rubens Alves, MSc, PhD of the Institut Pasteur São Paulo, Brazil, received a grant to integrate AI tools into influenza wastewater surveillance for real-time outbreak prediction and vaccine formulation support.
Mathew Evins, Chief Executive Officer of the GVN, noted, “The selected projects were chosen through a competitive review process and reflect the GVN’s commitment to advancing independent, data-driven research that strengthens the global response to viral threats.”
While each study is investigator-defined, together they represent a diverse portfolio of work spanning diagnostics, genomics, One Health, field surveillance, and AI-enhanced monitoring. “These awards are an important investment in local research leadership, particularly in regions on the front lines of emerging infectious diseases,” said Quarraisha Abdool Karim, PhD, co-director of the GVN Center of Excellence at CAPRISA, South Africa. “By equipping scientists in these communities with support and visibility, we help create a stronger, faster, and more equitable global response to mitigate future pandemic threats.”
For more information about GVN and future research opportunities, visit www.gvn.org.
Media Contact:
Nora Samaranayake
nsamaranayake@gvn.org
###
About the Global Virus Network
The Global Virus Network (GVN) is a worldwide coalition comprising 90+ Virology Centers of Excellence and Affiliates across 40+ countries, whose mission is to facilitate pandemic preparedness against viral pathogens and diseases that threaten public health globally. GVN advances knowledge of viruses through (i) data-driven research and solutions, (ii) fostering the next generation of virology leaders, and (iii) enhancing global resources for readiness and response to emerging viral threats. GVN provides the essential expertise required to discover and diagnose viruses that threaten public health, understand how such viruses spread illnesses, and facilitate the development of diagnostics, therapies, and treatments to combat them. GVN coordinates and collaborates with local, national, and international scientific institutions and government agencies to provide real-time virus informatics, surveillance, and response resources and strategies. GVN's pandemic preparedness mission is achieved by focusing on Education & Training, Qualitative & Quantitative Research, and Global Health Strategies & Solutions. The GVN is a non-profit 501(c)(3) organization. For more information, please visit www.gvn.org
END
BOSTON — Nov. 20, 2025 — Ginkgo Bioworks (NYSE: DNA) today announced the launch of the Virtual Cell Pharmacology Initiative (VCPI) through Ginkgo Datapoints. This open-source platform is designed to build the first standardized framework for virtual cell modeling in drug discovery by bringing together researchers, pharmaceutical companies and AI developers in a community-driven effort to create the largest public dataset of its kind, aiming to test at least 100,000 compounds and generate >12 billion data points.
Virtual cells, AI-powered digital representations of biological cells, are emerging as a critical ...
CLEVELAND—About 360 million years ago, the shallow sea above present-day Cleveland was home to a fearsome apex predator: Dunkleosteus terrelli. This 14-foot armored fish ruled the Late Devonian seas with razor-sharp bone blades instead of teeth, making it among the largest and most ferocious arthrodires—an extinct group of shark-like fishes covered in bony armor across their head and torso.
Since its discovery in the 1860s, Dunkleosteus has captivated scientists and the public alike, becoming ...
MINNEAPOLIS / ST. PAUL (11/20/2025) — A team of organic and computational chemists at the University of Minnesota Twin Cities have created a new, modern tool to make the process of creating pharmaceuticals and agrochemicals faster, cost-effective, and energy-efficient.
The research, recently published in Nature, details a new method for creating the essential starting materials, known as precursors, used in chemical reactions. A patent is pending for this technique.
Chemists use what are called “aryne intermediates” as building blocks to make complex molecules more efficiently in areas such as pharmaceuticals ...
COLUMBUS, Ohio – Many children grow up dreaming – or maybe even expecting – that they will become a star in football, basketball or whatever their favorite sport may be.
Most parents have more realistic expectations of their children’s future athletic achievement, a new study finds. But a substantial minority believe their kids will beat the odds and become collegiate, pro or even Olympic athletes.
In a survey of 785 American parents, 34% thought it was somewhat or very likely that their child would become a small-college athlete, 27% thought it was likely they would become a college scholarship athlete, and 17% thought it was somewhat ...
PALO ALTO, Calif. - November 20, 2025 - For millions of Americans in the African diaspora, genealogical ties and records were severed by the transatlantic slave trade, creating a "brick wall" for those seeking to know their full heritage. Today, 23andMe Research Institute announced a landmark expansion of its genetic ancestry reports and features, unveiling more than 250 high-resolution Genetic Groups across Africa. This significant update provides members with African heritage the most detailed and scientifically ...
Although present in very small amounts, selenium (Se)-based compounds play important roles in protecting the body from oxidative stress, regulating thyroid hormones, strengthening the immune system, and even detoxifying heavy metals. As we begin to understand more about the biological functions of Se, the need to detect and identify Se-containing compounds has become increasingly important.
Researchers from Chiba University, Japan, have developed a new method that selectively detects Se compounds, addressing a long-standing challenge in the identification of unknown Se-containing compounds. Using a previously unexplored approach, the researchers discovered novel Se-containing molecules in ...
A new oral GLP-1 medication can help adults with obesity and Type 2 diabetes lose more weight and improve their blood sugar levels compared to a placebo, according to findings from the ATTAIN-2 trial led by a UTHealth Houston researcher.
Obesity is a chronic health condition that can cause serious complications such as Type 2 diabetes, heart disease, high blood pressure, sleep apnea, certain cancers, and more. Current GLP-1 treatments for obesity consist of daily or weekly injectable medications that come with drawbacks, including the need for cold chain ...
A new paper outlines how scientists came together to put together the first microbial conservation roadmap under the leadership of Applied Microbiology International President, Professor Jack Gilbert.
The article, ‘Safeguarding Microbial Biodiversity: Microbial Conservation Specialist Group (MCSG) within the Species Survival Commission of the International Union for Conservation of Nature (IUCN)' is published in Sustainable Microbiology, an AMI journal.
In July 2025, IUCN formally launched the MCSG within its Species Survival Commission, co-chaired by Professor Gilbert and Raquel Peixoto (KAUST / ISME). This came out of a meeting ...
Our brain’s reward system processes and reinforces pleasurable experiences, motivating us to seek out and engage in rewarding activities ranging from eating to social interactions to recreational drug use. Dopamine plays an important role in this process, mediated by the D2 dopamine receptor (D2R). New research published today in Nature Neuroscience finds that the same mechanism that causes drug addiction (desensitization of D2R) also controls the natural devaluation of repeated behaviors (e.g. seeking out the same thrill of going on a rollercoaster for the first time). This is the first natural use found for this mechanism.
Researchers from ...
Bethesda, MD (Nov. 17, 2025) — The American Gastroenterological Association (AGA) has released a comprehensively updated clinical guideline on the pharmacological management of moderate-to-severe Crohn’s disease. The new guideline uses cutting-edge network meta-analyses to recommend prescribing medications based on patients’ prior treatments for moderate-to-severe Crohn’s disease.
The guideline organizes treatments by efficacy to simplify decision-making for gastroenterologists and over 3 million people worldwide living with Crohn’s disease. This living guideline reflects the rapid pace of innovation in medical ...
